JJ
J&J backs out of $1.1 billion hep C deal, wiping 22.2% from Achillion’s stock
September 12, 2017Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, achillion, hepatitis C, pharma
Johnson & Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to …
Has Trump’s power over pharma come to an end after Charlottesville?
August 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president
In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …
Johnson & Johnson face major lawsuit over vaginal mesh
July 4, 2017Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, vaginal mesh
Johnson & Johnson will face a lawsuit after 700 Australian women launched a class action suit over the failures of …
Actelion spin-off hit by blow shortly before buyout
June 9, 2017Medical Communications, Research and Development Actelion, Idorsia, J&J, JJ
Idorsia, the spin-off R&D company of Actelion, has been hit a blow even before it has left the ground. The …
J&J launches lawsuit to block release of Remicade biosimilar
May 19, 2017Medical Communications, Sales and Marketing J&J, JJ, Remicade, Samsung Bioepis
Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but …
FDA demands new warnings for J&J diabetes drug over amputation risk
May 17, 2017Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes
Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …
J&J ordered to pay $5m over false marketing claims
April 6, 2017Sales and Marketing J&J, JJ, lawsuit
Johnson & Johnson has become embroiled in yet another class-action lawsuit concerning its products; this time the company is accused …
Closure of Scottish J&J plant threatens 400 staff
March 10, 2017Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson
Johnson & Johnson has announced its intention to shut down its surgical suture manufacturing facility in Livingston, Scotland which sees …
Lilly posts impressive psoriasis results in comparison study
March 6, 2017Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly
Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …
J&J latest pharma firm to volunteer pricing data
February 28, 2017Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson
Johnson & Johnson released its pricing data, as promised, in February and it has simply revealed that its average price …
Integra bids $1.045 billion for J&J’s neurosurgery business
February 16, 2017Sales and Marketing Codman, Integra, J&J, JJ, Johnson & Johnson
Integra, a medical technology company, have announced that it has made a binding offer to acquire Johnson & Johnson’s Codman …
J&J breast implants “may have harmed thousands”, claims fresh lawsuit
February 6, 2017Sales and Marketing J&J, JJ, Mentor Worldwide, breast implants
Mentor Worldwide, a unit of US pharma firm Johnson & Johnson, has been accused of selling defective breast implants and …
22 pharma companies join forces for global non-communicable disease initiative
January 18, 2017Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda
The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
J&J hit by $1bn hip implant lawsuit
December 2, 2016Medical Communications J&J, JJ, lawsuit
Johnson & Johnson have been hit with yet another payout to patients who claim its products caused them harm. First, …
J&J reportedly poised to acquire Europe’s biggest biotech
November 25, 2016Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition
Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
